CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

Though threatened, new drug discoveries are still an American advantage A decade ago, China had just a few hundred pharmaceutical drugs actively in development. Today, China has thousands of drugs in ...